| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/23/2013 | CN103356892A Traditional Chinese medicine for treatment of tumor by nasal inhalation and perspiration methods |
| 10/23/2013 | CN103356859A Extraction of anti-cancer substance in asparagus |
| 10/23/2013 | CN103356837A Traditional Chinese medicament for treating digestive tract cancers |
| 10/23/2013 | CN103356832A Chinese medicinal composition and its preparation method |
| 10/23/2013 | CN103356831A Natural pharmaceutical composition and preparation method thereof |
| 10/23/2013 | CN103356829A Medicine for treating cancer of digestive tract |
| 10/23/2013 | CN103356814A Chinese medicinal composition, its preparation method and application |
| 10/23/2013 | CN103356810A Extracting method of novel antioxidant of tea flowers |
| 10/23/2013 | CN103356795A Chinese medicinal composition, its preparation method and application |
| 10/23/2013 | CN103356780A Natural pharmaceutical composition |
| 10/23/2013 | CN103356778A 中药组合物 Chinese medicine composition |
| 10/23/2013 | CN103356773A Traditional Chinese medicinal composition as well as preparation method and application thereof |
| 10/23/2013 | CN103356770A Composition used for preventing and treating tumor, and preparation method and application thereof |
| 10/23/2013 | CN103356769A Natural drug extract, preparation method and application thereof |
| 10/23/2013 | CN103356768A Natural pharmaceutical composition and preparation method thereof |
| 10/23/2013 | CN103356764A Berchemia lineate (L.) DC. extract with anti-tumor effect and preparation method of extract |
| 10/23/2013 | CN103356755A Natural medicinal composition, its preparation method and application |
| 10/23/2013 | CN103356754A Chinese medicinal composition |
| 10/23/2013 | CN103356745A Chinese medicinal mixed preparation for tumors |
| 10/23/2013 | CN103356743A Natural medicinal composition, its preparation method and application |
| 10/23/2013 | CN103356741A Natural medicine composition |
| 10/23/2013 | CN103356736A Dyetree fruit polyphenol extract with antineoplastic effect and preparation method thereof |
| 10/23/2013 | CN103356729A Chinese medicinal composition |
| 10/23/2013 | CN103356727A Breast cancer recovery capsule |
| 10/23/2013 | CN103356721A Traditional Chinese medicinal composition |
| 10/23/2013 | CN103356720A Natural pharmaceutical composition |
| 10/23/2013 | CN103356716A Fermented composition of multiple probiotics and composite medicinal and edible fungi, and preparation method and application thereof |
| 10/23/2013 | CN103356702A Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| 10/23/2013 | CN103356687A Use of ivermectin and its derivative |
| 10/23/2013 | CN103356641A Compound for inhibiting p-glycoprotein |
| 10/23/2013 | CN103356636A Theramutein调节剂 Theramutein moderator |
| 10/23/2013 | CN103356635A Application of Aspeverin in preparation of drug used for treating lung cancer |
| 10/23/2013 | CN103356634A Use of Aspeverin in preparation of drugs for treating leukemia |
| 10/23/2013 | CN103356619A Medicinal composition |
| 10/23/2013 | CN103356589A Application of Sarcaboside A in preparation of drug for treating cervical cancer |
| 10/23/2013 | CN103356585A Application of Sarcaboside B in preparation of medicines for treating bladder cancer |
| 10/23/2013 | CN103356581A Application of Sarcaboside A in preparation of drug for treating liver cancer |
| 10/23/2013 | CN103356578A Application of Sarcaboside A in preparation of drug for treating bile duct carcinoma |
| 10/23/2013 | CN103356577A Application of Sarcaboside A in preparation of drug for treating stomach cancer |
| 10/23/2013 | CN103356576A Application of Sarcaboside A in preparation of drug for treating lung cancer |
| 10/23/2013 | CN103356575A Application of Sarcaboside A in preparation of drug for treating prostatic cancer |
| 10/23/2013 | CN103356571A Application of Sarcaboside B in preparation of medicines for treating nasopharynx cancer |
| 10/23/2013 | CN103356568A Application of Sarcaboside A in preparing medicine for treating tongue cancer |
| 10/23/2013 | CN103356563A Application of Sarcaboside B in medicines for resisting lung cancer metastasis |
| 10/23/2013 | CN103356561A Application of Sarcaboside B in medicine used for treating renal cancer |
| 10/23/2013 | CN103356560A Application of Sarcaboside B in medicine used for treating prostate cancer |
| 10/23/2013 | CN103356559A Application of Sarcaboside B in preparation of medicines for treating tongue cancer |
| 10/23/2013 | CN103356557A Application of Sarcaboside B in preparation of medicines for treating liver cancer |
| 10/23/2013 | CN103356556A Application of Sarcaboside B in medicines for treating leukemia |
| 10/23/2013 | CN103356553A Application of Sarcaboside A in preparation of drug for treating breast cancer |
| 10/23/2013 | CN103356552A Application of Sarcaboside B in preparation of medicines for treating endometrial cancer |
| 10/23/2013 | CN103356550A Application of Sarcaboside B in medicine used for treating laryngeal cancer |
| 10/23/2013 | CN103356547A Application of Sarcaboside A in preparation of drug for treating skin cancer |
| 10/23/2013 | CN103356545A Application of Sarcaboside B in medicine used for treating ovarian cancer |
| 10/23/2013 | CN103356542A Application of Sarcaboside B in preparation of medicines for treating lung cancer |
| 10/23/2013 | CN103356541A Application of Sarcaboside B in medicine used for treating gastric cancer |
| 10/23/2013 | CN103356539A Application of Sarcaboside A in preparation of drug for treating colorectal cancer |
| 10/23/2013 | CN103356538A Application of Sarcaboside A in preparation of drug for treating ovarian cancer |
| 10/23/2013 | CN103356535A Application of Sarcaboside A in preparation of drug for treating pancreatic cancer |
| 10/23/2013 | CN103356534A Application of Sarcaboside B in medicine used for treating colorectal cancer |
| 10/23/2013 | CN103356532A Application of Sarcaboside B in medicine used for treating breast cancer |
| 10/23/2013 | CN103356531A Application of Sarcaboside B in medicine used for treating cervical cancer |
| 10/23/2013 | CN103356530A Application of Sarcaboside B in preparation of medicines for treating ileocecum cancer |
| 10/23/2013 | CN103356519A Application of dihydromyricetin in induction of cancer cell autophagy |
| 10/23/2013 | CN103356516A Small molecule anti-cancer drug based on mitogen-activated protein kinase kinase (MEK) and histone deacetylase (HDAC) double targets and preparation method of small molecule anti-cancer drug |
| 10/23/2013 | CN103356515A Application of emodin anthraquinone derivative in preparation of anti-hepatocellular carcinoma drugs |
| 10/23/2013 | CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes |
| 10/23/2013 | CN103356510A Methods for producing drug-containing bioabsorbable fibers |
| 10/23/2013 | CN103356504A 4-Amino-2-trifluoromethylphenylretinoate self-microemulsion and preparation method thereof |
| 10/23/2013 | CN103356499A Dextran-MLDH-fluorouracil supermolecular assembly magnetic targeting sustained release tablet |
| 10/23/2013 | CN103356495A Letrozole tablet and preparation method thereof |
| 10/23/2013 | CN103356492A Tripterine pharmaceutical composition using albumin as pharmaceutical carrier |
| 10/23/2013 | CN103356488A Capecitabine granule and preparation method thereof |
| 10/23/2013 | CN103356484A Magnetic solid "dextran-MLDH-fluorouracil" liposome |
| 10/23/2013 | CN103356483A Dextran-MLDH-fluorouracil super-molecular skeleton magnetic liposome |
| 10/23/2013 | CN103356477A Arctigenin-containing subcutaneous injection and application thereof |
| 10/23/2013 | CN103356476A Method for dissolving flavonoid compounds, carbon glycoside compounds or stilbene compounds and preparation method of injection or injectable powder injection |
| 10/23/2013 | CN103044423B Substituted pyridine-2-ketone compounds and preparation method thereof |
| 10/23/2013 | CN102872150B Application of Houttuynoid B in medicament for treating prostatic cancer |
| 10/23/2013 | CN102872134B Application of Houttuynoid D in drug for treating laryngocarcinoma |
| 10/23/2013 | CN102872123B Application of Houttuynoid C in medicament for treating bladder cancer |
| 10/23/2013 | CN102872121B Application of Houttuynoid C in medicament for treating laryngocarcinoma |
| 10/23/2013 | CN102872112B Application of Houttuynoid A in medicament for treating bladder cancer |
| 10/23/2013 | CN102872109B Application of Houttuynoid A in medicament for treating prostate cancer |
| 10/23/2013 | CN102872101B Application of Houttuynoid C in medicine for treating ileocecum cancer |
| 10/23/2013 | CN102872095B Application of Houttuynoid E in medicine for treating ileocecum cancer |
| 10/23/2013 | CN102872082B Application of Houttuynoid E in medicines for treating leukemia |
| 10/23/2013 | CN102872076B Application of Houttuynoid A in drugs for treating tongue cancer |
| 10/23/2013 | CN102872071B Application of Houttuynoid A to preparing drugs for resisting lung cancer metastasis |
| 10/23/2013 | CN102872069B Application of Houttuynoid C to preparing drugs for treating liver cancer |
| 10/23/2013 | CN102861059B Application of Houttuynoid D in pancreatic cancer treatment medicine |
| 10/23/2013 | CN102827257B Peptide fragment of gp96 protein and applications thereof |
| 10/23/2013 | CN102746995B Preparation method for isochromophilone VIII and application of same in preparation of antineoplastic drugs |
| 10/23/2013 | CN102732498B Application of protease tablysin to preparation of medicament for treating tumor |
| 10/23/2013 | CN102719432B Double-stranded asymmetric small nucleic-acid-interference-molecule asiRNA inhibiting tumour apoptosis suppressor specifically and application thereof |
| 10/23/2013 | CN102703447B Oligonucleotide with breast cancer treatment effect |
| 10/23/2013 | CN102702092B Eutectic of two curcumin organic medicaments and preparation method thereof |
| 10/23/2013 | CN102698256B Medicine composition for treating tumor and preparation method for medicine composition |
| 10/23/2013 | CN102698252B Medicine composition for treating tumor and preparation method for medicine composition |
| 10/23/2013 | CN102627597B Indole-3-carboxaldehyde isobutyryl hydrazone derivatives and preparation method thereof |